1. Arcadia Biosciences Raises $33 Million Series D Investment

    — Additional Capital to Fund Product Development and Regulatory Activities — DAVIS, Calif. (May 8, 2014) – Arcadia Biosciences, Inc., an agricultural biotechnology company focused on developing technologies and products that benefit the environment and human health, announced today that it has closed on a $33 million round of Series D preferred share equity financing….Continue Reading »